Booz Allen makes health analytics deal

Booz Allen Hamilton is giving its health analytics capabilities a boost with the acquisition of Epidemico, an informatics company in Boston.

The company develops products that can provide early insights, continuous monitoring and consumer engagement for varied aspects of population health, Booz Allen said in an announcement.

Terms of the deal were not disclosed.

Epidemico works on such problems as disease outbreaks, drug safety, supply chain vulnerabilities and other issues.

“The addition of Epidemico’s analytic capabilities to our data science team builds on the firm’s broader strategy of expanding its engineering and technology expertise to respond to the changing demands of government and commercial clients seeking more cost-effective and innovative solutions,” said Booz Allen President and Chief Operating Officer Horacio Rozanski.

One of Epidemico’s licensed products is HealthMap, which provides digital disease detection of over 200 infectious diseases worldwide in 15 languages.

The company is a spinoff of Boston Children’s Hospital, Harvard Medical School and the Massachusetts Institute of Technology.

Click here to read the entire press release.